Michallet, Mauricette <br/><br/>
Rituximab, fludarabine, and total body irradiation as conditioning regimen before allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukemia: long-term prospective multicenter study.  [electronic resource] 

 -  Experimental hematology  Feb 2013 
 - 127-33 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1873-2399 
<br/><br/><label>Standard No.: </label>10.1016/j.exphem.2012.10.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Graft Survival<br/>Graft vs Host Disease--etiology<br/>Graft vs Leukemia Effect<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kaplan-Meier Estimate<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Peripheral Blood Stem Cell Transplantation<br/>Prospective Studies<br/>Rituximab<br/>Salvage Therapy<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Vidarabine--administration & dosage<br/>Whole-Body Irradiation--adverse effects